Journal for ImmunoTherapy of Cancer (Feb 2022)
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers
- Akihito Kawazoe,
- Kohei Shitara,
- Chiara Cremolini,
- Giovanni Fucà,
- Sara Lonardi,
- Filippo Pietrantonio,
- Francesca Corti,
- Samuel J Klempner,
- Magali Svrcek,
- Thierry André,
- Giuseppe Curigliano,
- Michael Overman,
- Francesca Bergamo,
- Elisabetta Fenocchio,
- Massimiliano Salati,
- Margherita Ambrosini,
- Giovanni Randon,
- Lisa Salvatore,
- Romain Cohen,
- Raphael Colle,
- Priya Jayachandran,
- Maria Elena Elez,
- Marwan Fakih,
- Aakash Tushar Shah,
- Joseph Chao,
- Matthew Emmett,
- Marc Díez García,
- Giacomo Mazzoli,
- Leonardo Provenzano,
- Keigo Chida,
- Veronica Conca
Affiliations
- Akihito Kawazoe
- Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
- Kohei Shitara
- Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
- Chiara Cremolini
- Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
- Giovanni Fucà
- Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- Sara Lonardi
- Medical Oncology 3 and Medical Oncology 1, Istituto Oncologico Veneto IOV-IRCSS, Padua, Italy
- Filippo Pietrantonio
- Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- Francesca Corti
- Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- Samuel J Klempner
- Mass General Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
- Magali Svrcek
- Sorbonne Université, Department of Pathology, Hôpital Saint-Antoine, AP-HP, and INSERM, Unité Mixte de Recherche Scientifique 938, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France
- Thierry André
- Sorbonne Université, Department of Medical Oncology, Hôpital Saint-Antoine, AP-HP and INSERM, Unité Mixte de Recherche Scientifique 938, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France
- Giuseppe Curigliano
- European Institute of Oncology (IEO), IRCCS, Milan, Italy
- Michael Overman
- Department of Gastrointestinal Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- Francesca Bergamo
- Medical Oncology 1, Istituto Oncologico Veneto IOV-IRCSS, Padua, Italy
- Elisabetta Fenocchio
- Multidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute FPO-IRCCS, Candiolo, Italy
- Massimiliano Salati
- Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, PhD Clinical and Experimental Medicine (CEM), University of Modena and Reggio Emilia, Modena, Italy
- Margherita Ambrosini
- Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- Giovanni Randon
- Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- Lisa Salvatore
- Department of Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
- Romain Cohen
- Sorbonne Université, Department of Medical Oncology, Hôpital Saint-Antoine, AP-HP and INSERM, Unité Mixte de Recherche Scientifique 938, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France
- Raphael Colle
- Sorbonne Université, Department of Medical Oncology, Hôpital Saint-Antoine, AP-HP and INSERM, Unité Mixte de Recherche Scientifique 938, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France
- Priya Jayachandran
- Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
- Maria Elena Elez
- Department of Medical Oncology, Vall d`Hebron Barcelona Hospital Campus, Vall d`Hebron Institute of Oncology (VHIO), Universitat Autonoma de Barcelona, Barcelona, Spain
- Marwan Fakih
- Department of Medical Oncology and Therapeutic Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA
- Aakash Tushar Shah
- Baylor College of Medicine, Houston, Texas, USA
- Joseph Chao
- Department of Medical Oncology and Therapeutic Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA
- Matthew Emmett
- Mass General Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
- Marc Díez García
- Department of Medical Oncology, Vall d`Hebron Barcelona Hospital Campus, Vall d`Hebron Institute of Oncology (VHIO), Universitat Autonoma de Barcelona, Barcelona, Spain
- Giacomo Mazzoli
- Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- Leonardo Provenzano
- Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- Keigo Chida
- Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
- Veronica Conca
- Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
- DOI
- https://doi.org/10.1136/jitc-2021-004001
- Journal volume & issue
-
Vol. 10,
no. 2
Abstract
No abstracts available.
